PASG (Passage Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

PASG (Passage Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

PASGPassage Bio, Inc.

Mkt Cap$29M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$46M

EPS (TTM)-$14.35

Free Cash Flow (TTM)-$32M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$36M
Q2 23	$0	$0	-$25M
Q3 23	$0	$0	-$29M
Q4 23	$0	$0	-$18M
Q1 24	$0	$0	-$18M
Q2 24	$0	$0	-$17M
Q3 24	$0	$0	-$21M
Q4 24	$0	-$719K	-$14M
Q1 25	$0	$0	-$16M
Q2 25	$0	-$200K	-$10M
Q3 25	$0	$0	-$9M
Q4 25	$0	$200K	-$14M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$22M	-$22M
Q2 23	-$17M	-$17M
Q3 23	-$19M	-$19M
Q4 23	-$20M	-$20M
Q1 24	-$19M	-$19M
Q2 24	-$13M	-$13M
Q3 24	-$7M	-$7M
Q4 24	-$8M	-$8M
Q1 25	-$14M	-$14M
Q2 25	-$6M	-$6M
Q3 25	-$5M	-$5M
Q4 25	-$6M	-$6M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$26K
Q2 23	$103K
Q3 23	$4K
Q4 23	$13K
Q1 24	$0
Q2 24	$0
Q3 24	$20K
Q4 24	$14K
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-16.2%
Q2 23	—	-36.2%
Q3 23	—	+4.2%
Q4 23	—	-34.7%
Q1 24	—	-49.7%
Q2 24	—	-31.6%
Q3 24	—	-27.8%
Q4 24	—	-22.6%
Q1 25	—	-8.8%
Q2 25	—	-40.5%
Q3 25	—	-58.2%
Q4 25	—	-3.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	—
Q2 23	$4M	—
Q3 23	$3M	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$2M	—
Q3 24	$1M	—
Q4 24	$1M	—
Q1 25	$858K	—
Q2 25	$923K	—
Q3 25	$0	—
Q4 25	$609K	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$17M	$8M	—
Q2 23	$17M	$8M	—
Q3 23	$15M	$8M	—
Q4 23	$12M	$6M	—
Q1 24	$12M	$7M	—
Q2 24	$10M	$7M	—
Q3 24	$9M	$7M	—
Q4 24	$10M	—	$4M
Q1 25	$8M	$6M	—
Q2 25	$6M	$5M	—
Q3 25	$4M	$4M	—
Q4 25	$5M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$33M	$134M	$168M
Q2 23	$30M	$121M	$151M
Q3 23	$34M	$99M	$133M
Q4 23	$22M	$93M	$114M
Q1 24	$37M	$68M	$105M
Q2 24	$25M	$67M	$92M
Q3 24	$32M	$53M	$85M
Q4 24	$38M	$39M	$77M
Q1 25	$63M	$0	$63M
Q2 25	$58M	$0	$58M
Q3 25	$53M	$0	$53M
Q4 25	$46M	$0	$46M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	3M	+0.0%
Q2 23	3M	+0.1%
Q3 23	3M	+0.2%
Q4 23	3M	+0.3%
Q1 24	3M	+2.5%
Q2 24	3M	+9.6%
Q3 24	3M	+0.1%
Q4 24	3M	+0.5%
Q1 25	3M	+0.1%
Q2 25	3M	+2.0%
Q3 25	3M	+0.0%
Q4 25	3M	+0.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$0	74
FY 21	$0	133
FY 22	$0	85
FY 23	$0	58
FY 24	$0	60
FY 25	$0	200K